HOME
- About Us
- Stem Cells R&D
- Products and services
- Tissue & Cells Bank
- News
- Contact
Stem Cells R&D
Products and services
Stem Cells R&D
Products and services
development history
Twenty-nine years have witnessed our development from being born to being transformed, from ignorance to maturity, and from being a boat to becoming a giant.
It’s approved the EU Patent of "Industrial preparation of natural killer cells (NK) and injections of human allogeneic nucleated cells" in 2017
AVIC BIOLOGY acquired the financial support of the "National Major Infrastructure Project" in 2017
Western (Ningxia) human tissue cell bank officially opened in 2017
AVIC BIOLOGY listed on the New OTC Market in 2016, stock code: 839627
"Nuclear Cell Isolating Reagent Kit" obtained national secondary medical device registration certificate
AVIC BIOLOGY acquired the financial support for "National Innovation Capacity Building Project" in 2016
AVIC BIOLOGY successfully obtained the business license of Western (Ningxia) human tissue cell bank in 2015
AVIC BIOLOGY signed the strategic cooperation agreement with VITA34 Germany in 2015
The subsidiary established in 2015: Western (Ningxia) Human Tissue Cell Bank
The subsidiary established in 2015: AVIC BIOLOGY (Ningxia) cellular technology service Co., Ltd.
Mr. Wang Huailin, Chairman of AVIC BIOLOGY, won the “Chinese Patent Excellence Award" in 2015
The National Development and Reform Commission approved the establishment of the "National Clinical Research Center for Cell Therapy Technology" in 2015
It’s granted the patent “ Human allogeneic nucleated cells for the preparation of natural killer cells (NK) and injections ” in 2014
It was re-examined the national high-tech enterprise in 2014
" Large-scale culture denatured Cell (DC) project " was officially established in 2014
Our company has obtained ISO certification: 13485 in 2013
It’s approved "Research Center on Clinical Grade Cell Therapy Technology in Ningxia Hui Autonomous Region" in 2013
AVIC BIOLOGY has won the financial support of the "International Strategic Emerging Industries Project" in 2013
AVIC BIOLOGY won the title of "Little Giant Enterprise of Yinchuan" in 2013
"The human stem cell cosmetics project" formally established in 2013
"An optimized in vitro nucleate isolation kit and method of use" granted the patent in 2012
"Human-derived mesenchymal stem cells large-scale culture project" officially established in 2012
It’s approved " Medical Devices License Class II " in 2012
It’s approved "Innovative Pilot Unit of Ningxia Hui Autonomous Region" in 2012
AVIC Capital has controlled Ningxia Zhonglianda Biological Co., Ltd., the name of our company has changed to AVIC BIOLOGY in 2012
Our company has selected China Torch Program in 2012
Biomedical Engineering Academician Workstation in Ningxia Hui Autonomous Region was established in 2011
It’s approved "High-tech Enterprise in Ningxia Hui Autonomous Region " in 2011
Our company introduced the investment, capital rose from 1.5 million yuan to 26.5 million yuan in 2010
"A method for separating and extracting stem cells from the placenta, umbilical cord, or adipose tissue species" issued the patent in 2009
development history
Twenty-nine years have witnessed our development from being born to being transformed, from ignorance to maturity, and from being a boat to becoming a giant.
It’s approved the EU Patent of "Industrial preparation of natural killer cells (NK) and injections of human allogeneic nucleated cells" in 2017
AVIC BIOLOGY acquired the financial support of the "National Major Infrastructure Project" in 2017
Western (Ningxia) human tissue cell bank officially opened in 2017
AVIC BIOLOGY listed on the New OTC Market in 2016, stock code: 839627
"Nuclear Cell Isolating Reagent Kit" obtained national secondary medical device registration certificate
AVIC BIOLOGY acquired the financial support for "National Innovation Capacity Building Project" in 2016
AVIC BIOLOGY successfully obtained the business license of Western (Ningxia) human tissue cell bank in 2015
AVIC BIOLOGY signed the strategic cooperation agreement with VITA34 Germany in 2015
The subsidiary established in 2015: Western (Ningxia) Human Tissue Cell Bank
The subsidiary established in 2015: AVIC BIOLOGY (Ningxia) cellular technology service Co., Ltd.
Mr. Wang Huailin, Chairman of AVIC BIOLOGY, won the “Chinese Patent Excellence Award" in 2015
The National Development and Reform Commission approved the establishment of the "National Clinical Research Center for Cell Therapy Technology" in 2015
It’s granted the patent “ Human allogeneic nucleated cells for the preparation of natural killer cells (NK) and injections ” in 2014
It was re-examined the national high-tech enterprise in 2014
" Large-scale culture denatured Cell (DC) project " was officially established in 2014
Our company has obtained ISO certification: 13485 in 2013
It’s approved "Research Center on Clinical Grade Cell Therapy Technology in Ningxia Hui Autonomous Region" in 2013
AVIC BIOLOGY has won the financial support of the "International Strategic Emerging Industries Project" in 2013
AVIC BIOLOGY won the title of "Little Giant Enterprise of Yinchuan" in 2013
"The human stem cell cosmetics project" formally established in 2013
"An optimized in vitro nucleate isolation kit and method of use" granted the patent in 2012
"Human-derived mesenchymal stem cells large-scale culture project" officially established in 2012
It’s approved " Medical Devices License Class II " in 2012
It’s approved "Innovative Pilot Unit of Ningxia Hui Autonomous Region" in 2012
AVIC Capital has controlled Ningxia Zhonglianda Biological Co., Ltd., the name of our company has changed to AVIC BIOLOGY in 2012
Our company has selected China Torch Program in 2012
Biomedical Engineering Academician Workstation in Ningxia Hui Autonomous Region was established in 2011
It’s approved "High-tech Enterprise in Ningxia Hui Autonomous Region " in 2011
Our company introduced the investment, capital rose from 1.5 million yuan to 26.5 million yuan in 2010
"A method for separating and extracting stem cells from the placenta, umbilical cord, or adipose tissue species" issued the patent in 2009
AVIC BIOLOGY
Tel：400-889-9255
Focus on
Copyright © 2018 AVIC BIOLOGY
